AURORA: Crestor 10mg Versus Placebo in Subjects With End-stage Renal Disease (ESRD)
Status:
Completed
Trial end date:
2008-10-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to see if rosuvastatin helps to reduce the number of heart
attacks, strokes and cardiovascular deaths in patients undergoing haemodialysis.